Cost effectiveness and strategic planning (WHO-CHOICE)

AFR E: Cost effectiveness results for Cervical cancer

This Table provides summary results of the total population-level costs, effects and cost-effectiveness for the selected WHO sub-region and risk factor / disease for the year 2005.

KEY
I$ - International Dollars
Program Costs include costs of administration, media, training etc
Patient Costs include costs of hospital visits, drugs, etc
Incremental cost-effectiveness ratio (ICER) is defined as the incremental change in cost, divided by the incremental change in effectiveness. ICERs are reported for the successive set of interventions that would be selected at expanding levels of resource availability, starting with the intervention with the lowest cost per DALY averted, then moving to the next most cost-effective combination intervention out of the remaining available set of interventions.
Dominated is used to denote an intervention that is more costly and/or less effective than other, more efficient (single or combined) interventions; i.e. dominated interventions do not appear on the expansion path of most cost-effective strategies.


Interventions:Codes_and_Descriptions Coverage Cost per year (I$, millions) per one million_population [i.e. cost per capita] % Program costs % Patient costs DALYs averted per year per one million_population Average Cost per DALY averted Incremental Cost per DALY averted
CVC-1: Annual Papanicolau smear test [PAP] to persons aged 20-65 with lesion removal only 95% 1.27 40% 60% 364 3,502 Dominated
CVC-2: Tri-annual PAP smear to persons aged 20-65with lesion removal only 95% 0.68 28% 72% 313 2,166 Dominated
CVC-3: Visual inspection with acid [VIA] at age 40 with lesion removal only 95% 0.06 40% 60% 162 369 Dominated
CVC-4: Treatment [Rx] of invasive cancer (Surgery &/or Chemotherapy &/or Radiotherapy) 95% 0.24 0% 100% 606 401 702
CVC-5: Annual PAP smear to persons aged 20-65 with lesion removal and cancer treatment 95% 1.49 34% 66% 887 1,681 Dominated
CVC-6: Tri-annual PAP smear to persons aged 20-65 with lesion removal and cancer treatment. 95% 0.91 21% 79% 850 1,069 Dominated
CVC-7: VIA at age 40 with lesion removal and cancer treatment. 95% 0.36 7% 93% 758 475 Dominated
CVC-8: PAP smear every 5 years to persons aged 20-65 with lesion removal only 95% 0.44 27% 73% 287 1,552 Dominated
CVC-9: PAP smear every 5 years to persons aged 20-65 with lesion removal and cancer treatment 95% 0.69 18% 82% 828 830 Dominated
CVC-10: Annual PAP smear in ages 20-30, then annual PAP & HPV concurrent test from 30-65 with lesion removal only 95% 2.60 20% 80% 382 6,802 Dominated
CVC-11: Annual PAP smear in ages 20-30, then annual PAP & HPV concurrent test from 30-65 with lesion removal and cancer treatment 95% 2.66 14% 86% 904 2,941 Dominated
CVC-12: Tri-Annual PAP smear in ages 20-30, then Tri-annual PAP & HPV concurrent test from 30-65 with lesion removal only 95% 1.11 13% 87% 340 3,283 Dominated
CVC-13: Tri-Annual PAP smear in ages 20-30, then Tri-annual PAP & HPV concurrent test from 30-65 with lesion removal and cancer treatment 95% 1.24 4% 96% 872 1,421 Dominated
CVC-14: Five Yearly PAP smear in ages 20-30, then Five Yearly PAP & HPV concurrent test from 30-65 with lesion removal only 95% 0.71 13% 87% 322 2,206 Dominated
CVC-15: Five Yearly PAP smear in ages 20-30, then Five Yearly PAP & HPV concurrent test from 30-65 with lesion removal and cancer treatment 95% 0.93 10% 90% 857 1,091 Dominated
CVC-16: PAP smear at ages 35,40,45 with lesion removal only 95% 0.11 30% 70% 231 484 Dominated
CVC-17: PAP smear at ages 35,40,45 with lesion removal and cancer treatment 95% 0.42 8% 92% 809 522 Dominated
CVC-18: HPV test at ages 35,40,45 with lesion removal only 95% 0.32 10% 90% 256 1,239 Dominated
CVC-19: HPV test at ages 35,40,45 with lesion removal and cancer treatment 95% 0.60 6% 94% 821 728 Dominated
CVC-20: VIA inspection at ages 35,40,45 with lesion removal only 95% 0.13 25% 75% 249 524 Dominated
CVC-21: VIA inspection at ages 35,40,45 with lesion removal and cancer treatment 95% 0.41 8% 92% 816 505 Dominated
CVC-22: PAP at age 40 with lesion removal only 95% 0.05 39% 61% 144 328 Dominated
CVC-23: PAP at age 40 with lesion removal and cancer treatment 95% 0.35 5% 95% 745 471 Dominated
CVC-24: HPV test at age 40 with lesion removal only 95% 0.12 17% 83% 171 732 Dominated
CVC-25: HPV test at age 40 with lesion removal and cancer treatment 95% 0.42 4% 96% 764 552 Dominated
CVC-26: WANING HPV vaccination at age 12 costing $0.60 per dose 95% 0.08 9% 91% 237 333 Dominated
CVC-27: WANING HPV vaccination at age 12 costing $0.60 per dose + Rx 95% 0.41 2% 98% 786 523 Dominated
CVC-28: WANING HPV vaccination at age 12 costing $2.00 per dose 95% 0.16 4% 96% 237 670 Dominated
CVC-29: WANING HPV vaccination at age 12 costing $2.00 per dose + Rx 95% 0.50 1% 99% 786 633 Dominated
CVC-30: PAP(1,20,65)+Waning HPV at age 12 costing $0.60 per dose 95% 1.20 31% 69% 477 2,510 Dominated
CVC-31: PAP(3,20,65)+Waning HPV at age 12 costing $0.60 per dose 95% 0.70 20% 80% 448 1,553 Dominated
CVC-32: VIA at age 40 +Waning HPV at age 12 costing $0.60 per dose 95% 0.12 17% 83% 304 404 Dominated
CVC-33: PAP(1,20,65)+Waning HPV at age 12 costing $0.60 per dose+Rx 95% 1.41 26% 74% 971 1,456 27,139
CVC-34: PAP(3,20,65)+Waning HPV at age 12 costing $0.60 per dose+Rx 95% 0.92 15% 85% 950 970 12,425
CVC-35: VIA at age 40 +Waning HPV at age 12 costing $0.60 per dose+Rx 95% 0.42 5% 95% 834 500 972
CVC-36: PAP(5,20,65)+Waning HPV at age 12 costing $0.60 per dose 95% 0.48 19% 81% 429 1,122 Dominated
CVC-37: PAP(5,20,65)+Waning HPV at age 12 costing $0.60 per dose+Rx 95% 0.72 13% 87% 934 772 3,906
CVC-38: PAP (1,20,30) & PAP/HPV(1,30,65)+Waning HPV at age 12 costing $0.60 per dose 95% 2.52 15% 85% 489 5,147 Dominated
CVC-39: PAP (1,20,30) & PAP/HPV(1,30,65)+Waning HPV at age 12 costing $0.60 per dose + Rx 95% 2.73 14% 86% 984 2,773 100,075
CVC-40: PAP (3,20,30) & PAP/HPV(3,30,65)+Waning HPV at age 12 costing $0.60 per dose 95% 1.18 12% 88% 467 2,534 Dominated
CVC-41: PAP (3,20,30) & PAP/HPV(3,30,65)+Waning HPV at age 12 costing $0.60 per dose + Rx 95% 1.40 10% 90% 966 1,447 Dominated
CVC-42: PAP (5,20,30) & PAP/HPV(5,30,65)+Waning HPV at age 12 costing $0.60 per dose 95% 0.78 12% 88% 455 1,712 Dominated
CVC-43: PAP (5,20,30) & PAP/HPV(5,30,65)+Waning HPV at age 12 costing $0.60 per dose + Rx 95% 1.00 9% 91% 956 1,048 13,705
CVC-44: PAP (35,40,45)+Waning HPV at age 12 costing $0.60 per dose 95% 0.18 20% 80% 346 521 Dominated
CVC-45: PAP (35,40,45)+Waning HPV at age 12 costing $0.60 per dose+Rx 95% 0.49 7% 93% 866 564 Dominated
CVC-46: HPV (35,40,45)+Waning HPV at age 12 costing $0.60 per dose 95% 0.39 9% 91% 358 1,078 Dominated
CVC-47: HPV (35,40,45)+Waning HPV at age 12 costing $0.60 per dose+Rx 95% 0.66 5% 95% 874 758 Dominated
CVC-48: VIA (35,40,45)+Waning HPV at age 12 costing $0.60 per dose 95% 0.39 9% 91% 355 1,099 Dominated
CVC-49: VIA (35,40,45)+Waning HPV at age 12 costing $0.60 per dose+Rx 95% 0.48 8% 92% 872 550 1,675
CVC-50: PAP at age 40 +Waning HPV at age 12 costing $0.60 per dose 95% 0.12 18% 82% 296 391 Dominated
CVC-51: PAP at age 40 +Waning HPV at age 12 costing $0.60 per dose + Rx 95% 0.41 5% 95% 829 497 756
CVC-52: HPV test at age 40 + waning HPV at age 12 costing $0.60 per dose 95% 0.19 11% 89% 307 621 Dominated
CVC-53: HPV test at age 40 + waning HPV at age 12 costing $0.60 per dose + Rx 95% 0.48 4% 96% 837 579 Dominated
CVC-54: Annual PAP smear to persons aged 20-65 with lesion removal only. 80% 1.01 36% 64% 306 3,313 Dominated
CVC-55: Tri-annual PAP smear to persons aged 20-65 with lesion removal only. 80% 0.59 24% 76% 264 2,237 Dominated
CVC-56: VIA at age 40 with lesion removal only. 80% 0.05 37% 63% 137 398 Dominated
CVC-57: Treatment of invasive cancer consisting of Surgery &/or Chemotherapy &/or Radiotherapy 80% 0.17 0% 100% 413 403 Dominated
CVC-58: Annual PAP smear to persons aged 20-65 with lesion removal and cancer treatment 80% 1.17 31% 69% 685 1,703 Dominated
CVC-59: Tri-annual PAP smear to persons aged 20-65 with lesion removal and cancer treatment. 80% 0.75 19% 81% 651 1,154 Dominated
CVC-60: VIA at age 40 with lesion removal and cancer treatment. 80% 0.27 7% 93% 641 428 Dominated
CVC-61: PAP smear every 5 years to persons aged 20-65 with lesion removal only. 80% 0.39 23% 77% 241 1,618 Dominated
CVC-62: PAP smear every 5 years to persons aged 20-65 with lesion removal and cancer treatment 80% 0.56 16% 84% 631 887 Dominated
CVC-63: Annual PAP smear in ages 20-30, then annual PAP & HPV concurrent test from 30-65 with lesion removal only 80% 2.13 17% 83% 321 6,622 Dominated
CVC-64: Annual PAP smear in ages 20-30, then annual PAP & HPV concurrent test from 30-65 with lesion removal and cancer treatment 80% 2.17 12% 88% 700 3,103 Dominated
CVC-65: Tri-Annual PAP smear in ages 20-30, then Tri-annual PAP & HPV concurrent test from 30-65 with lesion removal only. 80% 0.97 11% 89% 286 3,397 Dominated
CVC-66: Tri-Annual PAP smear in ages 20-30, then Tri-annual PAP & HPV concurrent test from 30-65 with lesion removal and cancer treatment 80% 1.07 5% 95% 670 1,592 Dominated
CVC-67: Five Yearly PAP smear in ages 20-30, then Five Yearly PAP & HPV concurrent test from 30-65 with lesion removal only. 80% 0.62 11% 89% 271 2,298 Dominated
CVC-68: Five Yearly PAP smear in ages 20-30, then Five Yearly PAP & HPV concurrent test from 30-65 with lesion removal and cancer treatment. 80% 0.78 9% 91% 657 1,187 Dominated
CVC-69: PAP smear at ages 35,40,45 with lesion removal only. 80% 0.10 27% 73% 195 491 Dominated
CVC-70: PAP smear at ages 35,40,45 with lesion removal and cancer treatment. 80% 0.32 8% 92% 689 469 Dominated
CVC-71: HPV test at ages 35,40,45 with lesion removal only. 80% 0.27 10% 90% 216 1,268 Dominated
CVC-72: HPV test at ages 35,40,45 with lesion removal and cancer treatment. 80% 0.48 6% 94% 688 695 Dominated
CVC-73: VIA inspection at ages 35,40,45 with lesion removal only. 80% 0.12 22% 78% 210 569 Dominated
CVC-74: VIA inspection at ages 35,40,45 with lesion removal and cancer treatment. 80% 0.32 8% 92% 683 475 Dominated
CVC-75: PAP at age 40 with lesion removal only. 80% 0.04 37% 63% 121 339 Dominated
CVC-76: PAP at age 40 with lesion removal and cancer treatment . 80% 0.26 6% 94% 628 418 Dominated
CVC-77: HPV test at age 40 with lesion removal only. 80% 0.11 17% 83% 144 755 Dominated
CVC-78: HPV test at age 40 with lesion removal and cancer treatment . 80% 0.32 5% 95% 646 502 Dominated
CVC-79: WANING HPV vaccination at age 12 costing $0.60 per dose 80% 0.07 10% 90% 200 337 Dominated
CVC-80: WANING HPV vaccination at age 12 costing $0.60 per dose + Rx. 80% 0.30 2% 98% 580 510 Dominated
CVC-81: WANING HPV vaccination at age 12 costing $2.00 per dose 80% 0.13 5% 95% 200 675 Dominated
CVC-82: WANING HPV vaccination at age 12 costing $2.00 per dose + Rx. 80% 0.37 2% 98% 580 635 Dominated
CVC-83: PAP(1,20,65)+Waning HPV at age 12 costing $0.60 per dose 80% 0.97 28% 72% 401 2,417 Dominated
CVC-84: PAP(3,20,65)+Waning HPV at age 12 costing $0.60 per dose 80% 0.61 17% 83% 378 1,621 Dominated
CVC-85: VIA at age 40 +Waning HPV at age 12 costing $0.60 per dose 80% 0.11 17% 83% 256 422 Dominated
CVC-86: PAP(1,20,65)+Waning HPV at age 12 costing $0.60 per dose+RX 80% 1.12 24% 76% 749 1,498 Dominated
CVC-87: PAP(3,20,65)+Waning HPV at age 12 costing $0.60 per dose+Rx 80% 0.77 13% 87% 729 1,053 Dominated
CVC-88: VIA at age 40 +Waning HPV at age 12 costing $0.60 per dose+Rx 80% 0.31 6% 94% 624 498 Dominated
CVC-89: PAP(5,20,65)+Waning HPV at age 12 costing $0.60 per dose 80% 0.43 16% 84% 361 1,178 Dominated
CVC-90: PAP(5,20,65)+Waning HPV at age 12 costing $0.60 per dose+RX 80% 0.59 12% 88% 715 829 Dominated
CVC-91: PAP (1,20,30) & PAP/HPV(1,30,65)+Waning HPV at age 12 costing $0.60 per dose 80% 2.08 13% 87% 412 5,057 Dominated
CVC-92: PAP (1,20,30) & PAP/HPV(1,30,65)+Waning HPV at age 12 costing $0.60 per dose + RX 80% 2.23 12% 88% 760 2,935 Dominated
CVC-93: PAP (3,20,30) & PAP/HPV(3,30,65)+Waning HPV at age 12 costing $0.60 per dose 80% 1.03 10% 90% 393 2,618 Dominated
CVC-94: PAP (3,20,30) & PAP/HPV(3,30,65)+Waning HPV at age 12 costing $0.60 per dose + RX 80% 1.18 9% 91% 743 1,585 Dominated
CVC-95: PAP (5,20,30) & PAP/HPV(5,30,65)+Waning HPV at age 12 costing $0.60 per dose 80% 0.68 10% 90% 383 1,778 Dominated
CVC-96: PAP (5,20,30) & PAP/HPV(5,30,65)+Waning HPV at age 12 costing $0.60 per dose + RX 80% 0.84 8% 92% 734 1,138 Dominated
CVC-97: PAP (35,40,45)+Waning HPV at age 12 costing $0.60 per dose 80% 0.15 19% 81% 292 527 Dominated
CVC-98: PAP (35,40,45)+Waning HPV at age 12 costing $0.60 per dose+Rx 80% 0.37 8% 92% 654 561 Dominated
CVC-99: HPV (35,40,45)+Waning HPV at age 12 costing $0.60 per dose 80% 0.33 9% 91% 301 1,100 Dominated
CVC-100: HPV (35,40,45)+Waning HPV at age 12 costing $0.60 per dose+Rx 80% 0.52 5% 95% 662 790 Dominated
CVC-101: VIA (35,40,45)+Waning HPV at age 12 costing $0.60 per dose 80% 0.34 9% 91% 299 1,123 Dominated
CVC-102: VIA (35,40,45)+Waning HPV at age 12 costing $0.60 per dose+Rx 80% 0.37 8% 92% 660 564 Dominated
CVC-103: PAP at age 40 +Waning HPV at age 12 costing $0.60 per dose 80% 0.10 18% 82% 250 398 Dominated
CVC-104: PAP at age 40 +Waning HPV at age 12 costing $0.60 per dose + RX 80% 0.30 6% 94% 619 490 Dominated
CVC-105: HPV test at age 40 + waning HPV at age 12 costing $0.60 per dose 80% 0.16 11% 89% 259 634 Dominated
CVC-106: HPV test at age 40 + waning HPV at age 12 costing $0.60 per dose + RX 80% 0.37 5% 95% 627 585 Dominated
CVC-107: Annual PAP smear to persons aged 20-65 with lesion removal only. 50% 0.64 34% 66% 191 3,340 Dominated
CVC-108: Tri-annual PAP smear to persons aged 20-65 with lesion removal only. 50% 0.46 19% 81% 165 2,808 Dominated
CVC-109: VIA at age 40 with lesion removal only. 50% 0.05 34% 66% 85 555 Dominated
CVC-110: Treatment of invasive cancer consisting of Surgery &/or Chemotherapy &/or Radiotherapy 50% 0.07 0% 100% 182 405 Dominated
CVC-111: Annual PAP smear to persons aged 20-65 with lesion removal and cancer treatment 50% 0.71 30% 70% 390 1,821 Dominated
CVC-112: Tri-annual PAP smear to persons aged 20-65 with lesion removal and cancer treatment. 50% 0.54 16% 84% 365 1,470 Dominated
CVC-113: VIA at age 40 with lesion removal and cancer treatment. 50% 0.16 10% 90% 471 335 Dominated
CVC-114: PAP smear every 5 years to persons aged 20-65 with lesion removal only. 50% 0.31 18% 82% 151 2,074 Dominated
CVC-115: PAP smear every 5 years to persons aged 20-65 with lesion removal and cancer treatment 50% 0.39 15% 85% 352 1,110 Dominated
CVC-116: Annual PAP smear in ages 20-30, then annual PAP & HPV concurrent test from 30-65 with lesion removal only 50% 1.34 16% 84% 201 6,652 Dominated
CVC-117: Annual PAP smear in ages 20-30, then annual PAP & HPV concurrent test from 30-65 with lesion removal and cancer treatment 50% 1.35 12% 88% 399 3,370 Dominated
CVC-118: Tri-Annual PAP smear in ages 20-30, then Tri-annual PAP & HPV concurrent test from 30-65 with lesion removal only. 50% 0.72 9% 91% 179 4,028 Dominated
CVC-119: Tri-Annual PAP smear in ages 20-30, then Tri-annual PAP & HPV concurrent test from 30-65 with lesion removal and cancer treatment 50% 0.77 6% 94% 379 2,040 Dominated
CVC-120: Five Yearly PAP smear in ages 20-30, then Five Yearly PAP & HPV concurrent test from 30-65 with lesion removal only. 50% 0.47 9% 91% 169 2,779 Dominated
CVC-121: Five Yearly PAP smear in ages 20-30, then Five Yearly PAP & HPV concurrent test from 30-65 with lesion removal and cancer treatment. 50% 0.54 8% 92% 370 1,470 Dominated
CVC-122: PAP smear at ages 35,40,45 with lesion removal only. 50% 0.07 27% 73% 122 575 Dominated
CVC-123: PAP smear at ages 35,40,45 with lesion removal and cancer treatment. 50% 0.18 10% 90% 510 362 Dominated
CVC-124: HPV test at ages 35,40,45 with lesion removal only. 50% 0.19 10% 90% 135 1,427 Dominated
CVC-125: HPV test at ages 35,40,45 with lesion removal and cancer treatment. 50% 0.29 6% 94% 486 607 Dominated
CVC-126: VIA inspection at ages 35,40,45 with lesion removal only. 50% 0.10 18% 82% 131 792 Dominated
CVC-127: VIA inspection at ages 35,40,45 with lesion removal and cancer treatment. 50% 0.21 9% 91% 482 428 Dominated
CVC-128: PAP at age 40 with lesion removal only. 50% 0.03 40% 60% 76 414 Dominated
CVC-129: PAP at age 40 with lesion removal and cancer treatment . 50% 0.14 9% 91% 462 307 307
CVC-130: HPV test at age 40 with lesion removal only. 50% 0.08 19% 81% 90 875 Dominated
CVC-131: HPV test at age 40 with lesion removal and cancer treatment . 50% 0.19 7% 93% 475 391 Dominated
CVC-132: WANING HPV vaccination at age 12 costing $0.60 per dose 50% 0.04 14% 86% 125 355 Dominated
CVC-133: WANING HPV vaccination at age 12 costing $0.60 per dose + Rx. 50% 0.15 4% 96% 298 489 Dominated
CVC-134: WANING HPV vaccination at age 12 costing $2.00 per dose 50% 0.09 7% 93% 125 693 Dominated
CVC-135: WANING HPV vaccination at age 12 costing $2.00 per dose + Rx. 50% 0.19 3% 97% 298 642 Dominated
CVC-136: PAP(1,20,65)+Waning HPV at age 12 costing $0.60 per dose 50% 0.62 26% 74% 251 2,464 Dominated
CVC-137: PAP(3,20,65)+Waning HPV at age 12 costing $0.60 per dose 50% 0.48 14% 86% 236 2,028 Dominated
CVC-138: VIA at age 40 +Waning HPV at age 12 costing $0.60 per dose 50% 0.08 18% 82% 160 507 Dominated
CVC-139: PAP(1,20,65)+Waning HPV at age 12 costing $0.60 per dose+RX 50% 0.69 23% 77% 415 1,657 Dominated
CVC-140: PAP(3,20,65)+Waning HPV at age 12 costing $0.60 per dose+Rx 50% 0.55 12% 88% 401 1,368 Dominated
CVC-141: VIA at age 40 +Waning HPV at age 12 costing $0.60 per dose+Rx 50% 0.17 9% 91% 330 526 Dominated
CVC-142: PAP(5,20,65)+Waning HPV at age 12 costing $0.60 per dose 50% 0.34 14% 86% 226 1,488 Dominated
CVC-143: PAP(5,20,65)+Waning HPV at age 12 costing $0.60 per dose+RX 50% 0.41 11% 89% 392 1,054 Dominated
CVC-144: PAP (1,20,30) & PAP/HPV(1,30,65)+Waning HPV at age 12 costing $0.60 per dose 50% 1.31 12% 88% 257 5,105 Dominated
CVC-145: PAP (1,20,30) & PAP/HPV(1,30,65)+Waning HPV at age 12 costing $0.60 per dose + RX 50% 1.38 12% 88% 422 3,275 Dominated
CVC-146: PAP (3,20,30) & PAP/HPV(3,30,65)+Waning HPV at age 12 costing $0.60 per dose 50% 0.76 9% 91% 246 3,080 Dominated
CVC-147: PAP (3,20,30) & PAP/HPV(3,30,65)+Waning HPV at age 12 costing $0.60 per dose + RX 50% 0.83 8% 92% 411 2,010 Dominated
CVC-148: PAP (5,20,30) & PAP/HPV(5,30,65)+Waning HPV at age 12 costing $0.60 per dose 50% 0.51 9% 91% 239 2,123 Dominated
CVC-149: PAP (5,20,30) & PAP/HPV(5,30,65)+Waning HPV at age 12 costing $0.60 per dose + RX 50% 0.58 8% 92% 405 1,432 Dominated
CVC-150: PAP (35,40,45)+Waning HPV at age 12 costing $0.60 per dose 50% 0.11 20% 80% 182 588 Dominated
CVC-151: PAP (35,40,45)+Waning HPV at age 12 costing $0.60 per dose+Rx 50% 0.20 11% 89% 350 583 Dominated
CVC-152: HPV (35,40,45)+Waning HPV at age 12 costing $0.60 per dose 50% 0.23 9% 91% 188 1,218 Dominated
CVC-153: HPV (35,40,45)+Waning HPV at age 12 costing $0.60 per dose+Rx 50% 0.32 6% 94% 356 886 Dominated
CVC-154: VIA (35,40,45)+Waning HPV at age 12 costing $0.60 per dose 50% 0.23 9% 91% 187 1,251 Dominated
CVC-155: VIA (35,40,45)+Waning HPV at age 12 costing $0.60 per dose+Rx 50% 0.23 9% 91% 354 649 Dominated
CVC-156: PAP at age 40 +Waning HPV at age 12 costing $0.60 per dose 50% 0.07 22% 78% 156 441 Dominated
CVC-157: PAP at age 40 +Waning HPV at age 12 costing $0.60 per dose + RX 50% 0.16 9% 91% 326 494 Dominated
CVC-158: HPV test at age 40 + waning HPV at age 12 costing $0.60 per dose 50% 0.11 13% 87% 162 700 Dominated
CVC-159: HPV test at age 40 + waning HPV at age 12 costing $0.60 per dose + RX 50% 0.21 7% 93% 331 620 Dominated
Share